Tenax Therapeutics Inc (NASDAQ:TENX) shares rose nearly 8% to $0.50 in early trading Wednesday, following a recent pre-NDA meeting with the FDA.
Tenax Therapeutics Inc (NASDAQ:TENX) investors feel like they are in a nightmare, after the pharmaceutical company announced that the top-line results from its …